What is the appropriate treatment for canker sores (aphthous ulcers)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Canker Sores (Aphthous Ulcers)

For uncomplicated canker sores, topical corticosteroids are the first-line treatment, with topical hyaluronic acid-based gels serving as an effective alternative that promotes healing within the first week while avoiding steroid side effects 1.

Treatment Algorithm

For Simple, Uncomplicated Canker Sores

First-Line Options:

  • Topical corticosteroids remain the gold standard based on extensive clinical experience 1
  • Hyaluronic acid-based adhesive gels (such as medical device formulations) applied daily for 14 days show significant reduction in both lesion number and size within 3-6 days, with excellent safety profiles and no systemic side effects 2

Alternative Topical Agents:

  • Placental extract gel demonstrates effectiveness in reducing pain and ulcer size with notably lower recurrence rates compared to other topical treatments 3
  • Curcumin gel also reduces pain and ulcer size effectively, though it has higher recurrence rates and 40% of patients report unpleasant taste 3

When to Escalate Care

Consider biopsy and systemic workup if:

  • Ulcers persist beyond 2 weeks
  • No response to 1-2 weeks of topical treatment
  • Atypical presentation or multiple sites with different morphological characteristics 4

Pre-biopsy blood work should include:

  • Complete blood count (to exclude anemia, leukemia)
  • Coagulation studies
  • Fasting blood glucose
  • HIV antibody and syphilis serology
  • Consider serum autoantibodies (Dsg1, Dsg3, BP180, BP230) if bullous disease suspected 4

Systemic Treatment Considerations

Progress to systemic medications only when:

  • Disease is severe or progressive
  • Topical treatments fail
  • Underlying systemic disease is identified 1

Key Clinical Pearls

Diagnostic Features of Simple RAU:

  • Well-demarcated, oval or round ulcers
  • White or yellow pseudomembrane
  • Surrounding erythematous halo 4

Common Pitfalls to Avoid:

  • Do not dismiss ulcers lasting >2 weeks as "just canker sores"—these require biopsy to exclude malignancy or systemic disease 4
  • Hyperglycemia predisposes to fungal infections that can mimic aphthous ulcers 4
  • Multiple biopsies may be needed if ulcers involve multiple sites with different morphologies 4

Treatment Goals

The primary objectives are reducing pain, promoting rapid healing, and preventing recurrence 5. Hyaluronic acid-based gels achieve these goals with minimal side effects, making them particularly attractive for patients requiring repeated treatment courses 2. Topical corticosteroids, while effective, carry risks with prolonged use (2-3 weeks or longer), making them less ideal for frequently recurring cases 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.